Related Experiment Video
Updated: Jun 1, 2025

Generation of Induced Pluripotent Stem Cells from Human Peripheral T Cells Using Sendai Virus in Feeder-free Conditions
Published on: November 11, 2015
Generation of induced pluripotent stem cell line from a patient with long COVID
David Wu1, Amit Manhas2, Chikage Noishiki1
1Stanford Cardiovascular Institute, Stanford University School of Medicine, CA, USA; Division of Vascular Surgery, Department of Surgery, Stanford University School of Medicine, CA, USA.
Insights
Long COVID causes vascular dysfunction and increased clotting risk. Researchers created a stem cell line from a patient to study these long-term effects and multi-organ damage.
Area of Science:
- Stem cell biology
- Infectious disease research
- Vascular medicine
Background:
- Long COVID, or post-acute sequelae of SARS-CoV-2 infection, is linked to vascular dysfunction and multi-organ damage.
- COVID-19-associated coagulopathy (CAC) signifies an increased thrombotic risk in Long COVID patients.
- Understanding the mechanisms of Long COVID is crucial for developing effective treatments.
Purpose of the Study:
- To derive and characterize a human induced pluripotent stem cell (iPSC) line from a Long COVID patient.
- To establish a cellular model for investigating the pathogenesis of Long COVID.
- To facilitate research into the vascular and multi-organ complications associated with SARS-CoV-2 infection.
Main Methods:
- Peripheral blood mononuclear cells (PBMCs) were collected from a Long COVID patient.
- PBMCs were reprogrammed into induced pluripotent stem cells (iPSCs).
- The derived iPSC line was characterized for morphology, pluripotency, karyotype stability, and differentiation potential.
Main Results:
- A stable iPSC line was successfully derived from a Long COVID patient.
- The iPSC line exhibited normal morphology and maintained pluripotency.
- The iPSC line demonstrated successful differentiation into ectoderm, endoderm, and mesoderm germ layers.
Conclusions:
- The established iPSC line serves as a valuable tool for modeling Long COVID.
- This cellular model can aid in exploring the mechanisms of vascular dysfunction and multi-organ damage in Long COVID.
- Further research using this iPSC line may uncover novel therapeutic strategies for Long COVID complications.
Abstract:
Long COVID, or post-acute sequelae of SARS-CoV-2 infection, leads to vascular dysfunction, which contributes to the chronic multi-organ damage often seen in affected patients. Long COVID, a global health concern is associated with increased thrombotic risk, also known as COVID-19-associated coagulopathy (CAC). Here, we derived an induced pluripotent stem cell (iPSC) line from peripheral blood mononuclear cells (PBMCs) of a long COVID patient. This iPSC line showed normal morphology, maintained pluripotency, had a stable karyotype, and demonstrated the ability to differentiate into the three germ layers (ectoderm, endoderm, and mesoderm). This line provides a valuable tool for modeling long COVID and exploring mechanisms underlying multi-organ dysfunction.
More Related Videos
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
EPS and iPS Cells in Disease Research
iPS Cell Differentiation

